TARGETED THERAPY
Clinical trials for TARGETED THERAPY explained in plain language.
Never miss a new study
Get alerted when new TARGETED THERAPY trials appear
Sign up with your email to follow new studies for TARGETED THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Modified herpes virus joins forces with immunotherapy to attack head and neck tumors
Disease control OngoingThis study tests a combination of three treatments—immunotherapy (tislelizumab), targeted therapy (afatinib), and a modified herpes virus (lysogenic HSV)—given before surgery for head and neck squamous cell carcinoma. The goal is to see if this approach safely shrinks tumors and …
Matched conditions: TARGETED THERAPY
Phase: PHASE1, PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New combo therapy shows promise for untreatable liver cancer
Disease control OngoingThis study looks at whether a three-part treatment—blocking the tumor's blood supply (TACE), precise radiation (SBRT), and drugs that boost the immune system—can help people with intermediate to advanced liver cancer that cannot be removed by surgery. The 17 participants all rece…
Matched conditions: TARGETED THERAPY
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC